Hims & Hers Health is preparing to release its Q1 2025 financial results, with expectations of $260.91 million revenue and earnings per share of $0.03. The company has evolved from a startup focused on menâs health issues to a comprehensive digital health platform. CEO Andrew Dudum envisions 2024 as a pivotal year for validation regarding its business model. With 2.2 million subscribers and strong financial growth, the upcoming earnings will test the company's success, especially with new programs in place aiming to increase revenue.
Analysts expect Hims to post revenue of $260.91 million and earnings per share of $0.03, marking a critical test for their ongoing growth.
CEO Andrew Dudum describes 2024 as a validation year, emphasizing the importance of Hims' integrated model for scale and affordability in healthcare.
Collection
[
|
...
]